Robert Redner, MD: Clinical Trials

1 trial sponsored by Robert Redner, MD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Robert Redner, MD: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma
Bendamustine, Lenalidomide, Dexamethasone - Myeloma
Phase 1CompletedRobert Redner, MD292008-02-012017-07-31

Conditions studied

Neoplasms, Plasma Cell (1)

Interventions

Anti-Bacterial Agents (1)  ·  Aspirin (1)  ·  Bendamustine Hydrochloride (1)  ·  Dexamethasone (1)  ·  Lenalidomide (1)

Countries

United States (1)

Top investigators

Robert L Redner, M.D. (1)

Results publications

PMID 22451423